IXC 5.56% 7.6¢ invex therapeutics ltd

Ann: Phase II Clinical Results and Capital Raising Presentation, page-23

  1. 1,433 Posts.
    lightbulb Created with Sketch. 840

    I appreciate the input here mate. I hope that the below fills in some gaps as to the potential phase 3 methodology:

    IXC Twitter Account retweeted this link 6 days ago:

    https://www.birminghamhealthpartners.co.uk/new-non-invasive-technique-measures-brain-swelling/

    Titled "New Non Invasive Technique Measures Brain Swelling"

    https://hotcopper.com.au/data/attachments/2616/2616153-ea632b3caa6c70bddab7fb148da9f4e7.jpg
    It really does look like a massive innovation for IIH sufferers, many responses to the tweet were IIH patients glee in learning that they do not require lumbar punctures any more. I imagine that they would be using this method in phase 3, although I believe headaches were the only required endpoint?

    I'm unsure why that rings a bell - I could be wrong. Regardless, as this process is now non invasive, Im sure they would collect data.
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.6¢
Change
0.004(5.56%)
Mkt cap ! $5.711M
Open High Low Value Volume
7.5¢ 7.6¢ 7.5¢ $167 2.216K

Buyers (Bids)

No. Vol. Price($)
1 40000 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.3¢ 4000 1
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.